Susquehanna International Group
PACB icon

Susquehanna International Group’s Pacific Biosciences PACB Stock Holding History

Susquehanna International Group’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$714K Sell
541,000
-93,000
-15% -$166K ﹤0.01% 8766
2025
Q4 		$1.19M Buy
634,000
+411,600
+185% +$791K ﹤0.01% 6805
2025
Q3 		$285K Sell
222,400
-38,400
-15% -$52K ﹤0.01% 10242
2025
Q2 		$323K Buy
260,800
+17,800
+7% +$20.6K ﹤0.01% 10168
2025
Q1 		$287K Sell
243,000
-584,400
-71% -$896K ﹤0.01% 10157
2024
Q4 		$1.51M Buy
827,400
+411,300
+99% +$803K ﹤0.01% 5939
2024
Q3 		$707K Sell
416,100
-25,500
-6% -$41.9K ﹤0.01% 7626
2024
Q2 		$605K Buy
441,600
+7,800
+2% +$15.8K ﹤0.01% 7804
2024
Q1 		$1.63M Buy
433,800
+246,500
+132% +$1.44M ﹤0.01% 5809
2023
Q4 		$1.84M Sell
187,300
-51,200
-21% -$419K ﹤0.01% 5547
2023
Q3 		$1.99M Buy
238,500
+25,600
+12% +$293K ﹤0.01% 5145
2023
Q2 		$2.83M Buy
212,900
+48,700
+30% +$592K ﹤0.01% 4468
2023
Q1 		$1.9M Buy
164,200
+11,300
+7% +$112K ﹤0.01% 5254
2022
Q4 		$1.25M Sell
152,900
-46,000
-23% -$396K ﹤0.01% 5700
2022
Q3 		$1.16M Buy
198,900
+62,700
+46% +$360K ﹤0.01% 6267
2022
Q2 		$602K Buy
136,200
+29,300
+27% +$178K ﹤0.01% 7811
2022
Q1 		$973K Sell
106,900
-23,800
-18% -$274K ﹤0.01% 7192
2021
Q4 		$2.67M Sell
130,700
-161,200
-55% -$3.89M ﹤0.01% 4853
2021
Q3 		$7.46M Buy
291,900
+117,700
+68% +$3.49M ﹤0.01% 3304
2021
Q2 		$6.09M Sell
174,200
-30,800
-15% -$896K ﹤0.01% 3659
2021
Q1 		$6.83M Sell
205,000
-102,800
-33% -$3.6M ﹤0.01% 3375
2020
Q4 		$7.98M Buy
307,800
+281,300
+1,062% +$4.78M ﹤0.01% 2774
2020
Q3 		$262K Buy
26,500
+9,000
+51% +$51.8K ﹤0.01% 8974
2020
Q2 		$60K Sell
17,500
-16,500
-49% -$56.2K ﹤0.01% 9702
2020
Q1 		$104K Sell
34,000
-48,100
-59% -$197K ﹤0.01% 9297
2019
Q4 		$422K Sell
82,100
-11,700
-12% -$59.5K ﹤0.01% 7310
2019
Q3 		$484K Buy
93,800
+76,400
+439% +$427K ﹤0.01% 7376
2019
Q2 		$105K Sell
17,400
-31,400
-64% -$220K ﹤0.01% 9586
2019
Q1 		$353K Sell
48,800
-9,300
-16% -$67.3K ﹤0.01% 6927
2018
Q4 		$430K Sell
58,100
-6,800
-10% -$43.1K ﹤0.01% 6320
2018
Q3 		$351K Buy
64,900
+12,000
+23% +$51.5K ﹤0.01% 7171
2018
Q2 		$188K Buy
52,900
+9,800
+23% +$27.2K ﹤0.01% 8667
2018
Q1 		$88K Sell
43,100
-36,300
-46% -$94.3K ﹤0.01% 8747
2017
Q4 		$210K Sell
79,400
-11,300
-12% -$39.6K ﹤0.01% 8205
2017
Q3 		$476K Sell
90,700
-17,200
-16% -$73.9K ﹤0.01% 6601
2017
Q2 		$384K Sell
107,900
-188,700
-64% -$761K ﹤0.01% 7133
2017
Q1 		$1.53M Sell
296,600
-26,600
-8% -$130K ﹤0.01% 4226
2016
Q4 		$1.23M Sell
323,200
-75,800
-19% -$551K ﹤0.01% 5088
2016
Q3 		$3.58M Sell
399,000
-51,100
-11% -$427K ﹤0.01% 2657
2016
Q2 		$3.17M Buy
450,100
+232,100
+106% +$2.12M ﹤0.01% 2855
2016
Q1 		$1.85M Buy
218,000
+51,600
+31% +$507K ﹤0.01% 3930
2015
Q4 		$2.19M Buy
166,400
+127,900
+332% +$1.15M ﹤0.01% 3850
2015
Q3 		$141K Sell
38,500
-7,600
-16% -$37.2K ﹤0.01% 8962
2015
Q2 		$266K Buy
46,100
+23,400
+103% +$135K ﹤0.01% 8760
2015
Q1 		$133K Buy
22,700
+1,500
+7% +$10.3K ﹤0.01% 8862
2014
Q4 		$166K Sell
21,200
-7,800
-27% -$49.9K ﹤0.01% 8949
2014
Q3 		$142K Sell
29,000
-22,000
-43% -$115K ﹤0.01% 8927
2014
Q2 		$315K Buy
51,000
+21,400
+72% +$107K ﹤0.01% 8292
2014
Q1 		$158K Buy
29,600
+5,500
+23% +$34.8K ﹤0.01% 8390
2013
Q4 		$126K Buy
+24,100
New +$111K ﹤0.01% 8550

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group's PACB Position: Q1 2026 in Review

Susquehanna International Group reduced its Pacific Biosciences (PACB) stake by 34% in Q1 2026, selling an estimated $1.6M and leaving 1,719,165 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #5872.

Susquehanna International Group first reported a position in PACB in Q2 2013 and has held it in 48 quarters since. The position peaked at $15.3M in Q4 2020. 230 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

  • Susquehanna International Group held 1,719,165 shares of Pacific Biosciences worth $2.27M as of Q1 2026.
  • Susquehanna International Group sold 892,378 Pacific Biosciences shares in Q1 2026, an estimated $1.6M.
  • Pacific Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5872 holding.
  • Susquehanna International Group first reported a position in Pacific Biosciences in Q2 2013 and has held it in 48 quarters since.
  • Susquehanna International Group's Pacific Biosciences position peaked at $15.3M in Q4 2020.
  • 230 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.